Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
RenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025
-
Showcasing the Vibrant Lifestyle of Seoul: 2024 Runway to Seoul
-
Trulieve to Open New Dispensary in Maricopa, Arizona
-
Pace of U.S. Small Business Job Growth Moderated in 2024
-
AI Proteins Enters into Collaborative Research Agreement with the University of Missouri on Radioligand Therapy
-
Nominations Open for the 2025 50 Fastest Growing Women-Owned/Led Companies, presented by The Women Presidents Organization and JPMorgan Chase Commercial Banking
-
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
-
Republic Bank named one of America’s Best Regional Banks for the second consecutive year
-
Tonal Ushers In The Future Of Fitness With Tonal 2 – Designed To Improve Performance And Build Muscle Faster
-
TriSalus Announces Leadership Changes
-
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Built In Honors Evolv Technology in Its Esteemed 2025 Best Places To Work Awards
-
ONI Launches Aplo Scope to Revolutionize Single Molecule Super-Resolution Microscopy
-
Darktrace Appoints Bryce Coté as Chief Customer Officer
-
Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Emerging Clinical-Stage Neuroscience Company Nuvie Bio Announces Positive Phase 1 Data with its Lead Migraine Program
-
Bitdeer Announces December 2024 Production and Operations Update
-
ViGeneron Announces FDA Rare Pediatric Disease Designation for VG901 and DSMB Approval to Advance Dose Escalation in Phase 1b Retinitis Pigmentosa Trial
-
Tokyo Lifestyle Co., Ltd. to Open A New Directly-Operated Store in Hong Kong
-
Infinite Reality Raises $3 Billion; Moves Valuation to $12.25 Billion
-
Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
-
AXIL Brands Reports Second Quarter Fiscal Year 2025 Financial Results
-
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
-
Sky Quarry Receives Permission to Operate Fractionation Facility at Eagle Springs Refinery Site, Advancing Waste-to-Energy Vision
-
U.S. Retail Media Veteran Joins Particular Audience to Accelerate U.S. and European Growth—and Build Retail Media the Way It Was Meant to Be
-
PodcastOne (NASDAQ: PODC) Named 8th Largest US Podcast Publisher by Podtrac for December 2024; Renews Flagship Podcasts with Adam Carolla, Brendan Schaub and Kaitlyn Bristowe
-
UMeWorld Transforms into a Full-Spectrum Wellness Brand with AI-Powered Personalized Solutions
-
Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Socially Responsible Spending Is Still Trending in the Right Direction Despite Slight Decline from Previous Year, According to 12th Annual Conscious Consumer Spending Index
-
Acres Debuts Layer Library: Combine and Visualize Land Data Seamlessly
-
authID Receives Industry Luminary Classification in The Prism Project’s 2024 Biometric Digital Identity Flagship Report
-
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
-
Magna International Inc. Announces Date for Q4 & Year End 2024 Results and 2025 Outlook Webcast
-
Bitcoin Depot Expands BTM Network Through Partnership with Prominent Texas Convenience Store Chain
-
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
-
Kratos Awarded $48 Million Contract for Geolocation Global Support Services
-
STACK Infrastructure Advances Data Center Safety and Releases Breaker Guard Design into Public Domain
-
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies
-
Acronis Appoints Gerald Beuchelt as Chief Information Security Officer
-
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
-
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
-
Advanced Ionics Raises $6.7M to Accelerate Technology Commercialization and Deployment
-
Blimburn Seeds Announces USA Expansion
-
Collegium Provides 2025 Financial Guidance and Business Update
-
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Live Oak Bancshares, Inc. Announces Date of Fourth Quarter 2024 Financial Results
-
New TransUnion Research Reveals Seven in 10 Marketing Leaders Struggle to Connect with Audiences Due to Complex Network of Martech Solutions and Identity Challenges
-
Bonaccord Capital Partners Announces Fund II Final Close at $1.6 Billion
-
Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
